WO2024257066A2 - Smart device for digitally adapting the state of a substance to be consumed - Google Patents

Abstract

The invention relates to a smart device for adapting the consumption of substances in a manner which is specific to the consumer, comprising • a device for receiving an identification and processing a substance to be consumed, • at least one substance to be consumed which can be uniquely identified by means of a sensory characteristic, such as a QR code or a sensor chip, • at least one mobile unit which is worn on the consumer-side and/or near the body, • at least one wireless network communication between all of the users of worn units, • at least one wireless network connection to a central or decentralized data server in order to exchange the data detected on the consumer side, and • at least one interface for medical specialists for evaluating the data detected on the consumer side. The invention additionally relates to an aerosol-forming device.

Description

Smart device for digitally adjusting the state of a substance to be consumed

The present invention relates to a smart device for digitally adjusting the state of a substance to be consumed and to a corresponding method.

One of the preferred substances for the purposes of the present invention is cannabis, especially medical cannabis.

Medical cannabis can be used for various conditions, especially in cases where conventional medications do not help patients sufficiently or in cases of serious side effects. Scientific studies show that cannabis does not cure any disease or illness, but it can alleviate symptoms or inhibit the development of a disease. Based on randomized, double-blind, controlled clinical data, cannabinoids have been shown to be therapeutically effective in chronic pain, multiple sclerosis, nausea, vomiting and appetite, Gilles de la Tourette syndrome, glaucoma.

Cannabinoids also show promising results in the symptomatic treatment of hyperactivity, anxiety and allergies. In addition to medical treatment, patients often experiment with self-medication in various forms. Cannabis is used for conditions such as anxiety, cancer, epilepsy, inflammatory bowel disease, Parkinson's disease, psychiatric disorders, insomnia/sleep disorders, hyperactivity, anxiety disorders and allergies.

Dosage varies from patient to patient. It is important that dosage is titrated (increased) slowly, regardless of the product. The focus is on determining the right dose for each individual patient in order to really reap all the benefits of medical cannabis. It is better to take several small doses throughout the day that will achieve the desired result overall, rather than experimenting with a high dose. Cannabis can have different effects from patient to patient. You should wait until the effects occur (or not). It is best to use the same (low) dose for several days and monitor the effects

After a few days, the patient can increase the dose, but only slowly. Wait a few days after each dose increase to determine progress. Within about one to two weeks, patients should be able to determine their own personal dose that produces the greatest medical effect with minimal side effects.

By establishing a treatment protocol, overdose can usually be avoided. If a patient takes too high doses of THC, the side effects mentioned above may occur.

Some patients experience an unwanted high. This can be prevented by using a lower dosage or increasing the dosage slowly over a longer period of time.

Undesirable side effects and risks occur primarily after consuming high doses or when medical cannabis is consumed in combination with other substances that enhance the effect, such as certain medications. When administered correctly, medical cannabis has no identified toxic effects on the health of patients. The common acute side effects of high doses of cannabis occur very quickly after consumption and include increased heart rate, reduced blood pressure, dizziness, dry mouth, red eyes, increased appetite, mild euphoria (avoid drug high), reduced alertness after consumption.

The principles of the present invention are summarized as follows:

I. Smart device for digitally adjusting the state of a substance to be consumed, comprising a device for receiving an inserted substance to be consumed, which is designed to bring the substance into a consumable state, in particular an aggregate state, whereby the substance to be consumed can be identified by the device through a sensory feature, such as a QR code or a sensor chip.

II. Smart device according to point I, wherein the device is connected to a mobile unit, such as a smartphone, which is designed to retrieve data and/or instructions stored for the substance to be consumed via an app or access to a cloud and to execute them via a digital connection to the device.

III. Smart device according to item I or II, wherein the device and/or the mobile unit is connected to a body-worn device, such as a smart watch or the like, wherein the body-worn device is designed to record physical and/or physical and/or chemical data of a person wearing the body-worn device, to compare them with the stored data and/or instructions and to interact based on the comparison.

IV. Smart device according to point I, whereby the substance to be consumed can only be released in predefined quantities, units or time periods.

V. Multi-evaporation device comprising a device for evaporating a vaporizable substance and a receiving device for substance containers, wherein the receiving device is designed to receive at least two substance containers simultaneously, which can be alternately connected to the device for evaporation.

VI. Multi-vaporizer according to item V, wherein the device for vaporizing a vaporizable substance is the device for receiving an inserted substance to be consumed according to one of claims 1 to 4.

VII. Multi-evaporation device according to item V, wherein the receiving device is designed like a revolver.

VIII. Multi-evaporation device according to item V, wherein the receiving device is designed like a magazine. IX. Multi-vaporizer according to item V, wherein in addition to a first carrier for flavors, at least a second carrier for flavors is provided in the device.

X. Multi-vaporizer according to item IX, wherein the first carrier for flavors and the second carrier for flavors are separate from each other, preferably in two separate components.

XI. Multi-vaporizer according to item IX or X, wherein the second carrier is positioned so that the created vapor mixture can mix from the aroma from the first carrier and the second carrier.

In a first embodiment of the first aspect, the present invention relates to a smart device for consumer-specific adaptation of the consumption of substances, comprising a device for receiving, identifying and processing an inserted substance to be consumed, at least one inserted substance to be consumed which is clearly identifiable by a sensory feature such as a QR code or a sensor chip, at least one mobile unit worn by the consumer and/or close to the body, at least one wireless network communication between all units worn by users, at least one wireless network connection to a central or decentralized data server for exchanging the data recorded by the consumer, at least one interface for medical professionals for assessing the data recorded by the consumer.

An alternative embodiment relates to a smart device for digitally adjusting the state of a substance to be consumed, wherein the device for receiving an inserted substance to be consumed is designed to bring the substance into a consumable state, in particular an aggregate state, and is identifiable by the device through a sensory feature, such as a QR code or a sensor chip. A further development of the two above embodiments provides that the device and/or the mobile unit is/are connected to a body-worn device, such as a smart watch or the like, via a wireless data interface, wherein the body-worn device is designed to record physical and/or physical and/or chemical and/or pharmacological data of a person wearing the body-worn device, to compare it with the stored data and/or instructions and to interact based on the comparison, wherein an exchange of data takes place with a central or decentralized data server.

Furthermore, it is preferred for the smart device if the device is connected to a mobile unit, such as a smartphone, which is designed to retrieve data and/or instructions stored for the at least one substance to be consumed via an app or direct access to a central or decentralized data server and to execute these via a digital connection to the device, as well as to send data obtained via the mobile unit worn close to the body to the central or decentralized data server.

Another further development of the smart device provides that the substance to be consumed can be released by medical professionals in predefined quantities, units or time periods, whereby the active ingredient concentration and the amount of active ingredient released can be regulated by setting the temperature or using a nebulizer unit, and the absorption can be monitored by monitoring the inhalation behavior (duration, depth).

The smart device according to the invention can further be designed in such a way that the data obtained by the body-hugging unit and sent to the central or decentralized data server via the mobile unit, such as the smartphone, can be processed there and compared with consumer-specific data typical of the disease or scientific study databases in such a way that the consumer receives a recommendation via the mobile unit, such as the smartphone, with information on the dosage and type of at least one substance for preventing or alleviating acute attacks of the disease, in a temporally close connection with the data collected. Alternatively, the data obtained by the body-worn unit and sent to the central or decentralized data server via the mobile unit, such as the smartphone, can be processed there and compared with consumer-specific data typical of the disease or scientific study databases in such a way that the consumer receives a recommendation via the mobile unit, such as the smartphone, with information on the dosage and type of at least one substance to prevent or alleviate permanent disease patterns, in a closely temporal connection with the data collected.

The two aforementioned alternatives can be developed in such a way that the consumer receives the recommendation with information on the dosage and type of at least one substance at fixed time intervals.

A second aspect of the present invention relates to an aerosol-forming device comprising a device for converting at least one substance into an aerosol or a state of aggregation, a receiving device for substance containers, wherein the receiving device is designed to receive at least two substance containers simultaneously, which can be alternately connected to the device for vaporization.

One embodiment of the aerosol-forming device provides that the device for converting a substance into an aerosol or a state of aggregation is the device for receiving an inserted substance to be consumed, as described above.

In an alternative embodiment of the aerosol-forming device, the receiving device for substance containers is designed like a revolver drum and the fill level can be displayed either directly on the substance container or via a display on the aerosol-forming device or via an app.

Another alternative is an aerosol-forming device in which the receiving device is designed like a magazine and the fill level can be displayed either directly on the substance container or via a display on the aerosol-forming device or via an app. A special embodiment provides that the aroma to be vaporized can be selected from the at least two substances in the magazine, using the revolver drum-like mechanism.

It has been found to be advantageous in the aerosol-forming device according to the invention that the substances can be mixed with one another in a freely selectable ratio controlled mechanically by the consumer or digitally via the app before they are vaporized from a collecting container provided for this purpose, and that they can be processed from at least two substances in a temperature-specific manner by several steam generators within the aerosol-forming device and a consumer-specific steam mixture can be set.

Finally, a further development concerns the aerosol-forming device in which the composition of at least two substances mixed together can be stored at least on the smartphone or on the central or decentralized data server and can thus be accessed by other consumers at any time.

The present invention focuses on the formation of an aerosol from corresponding substances to be consumed. For the purposes of the present invention, "aerosol" includes smoke, vapor, mist, which can be created by evaporation, combustion, etc.

The substances to be consumed can be in various forms, such as solids, ground solids, liquids, liquids, oils. Solids are usually burned, liquids are usually vaporized. The above conversion of these substances into a suitable state of aggregation is carried out using an aerosol-forming device.

Further aims, features, advantages and possible applications emerge from the following description of non-limiting embodiments of the invention with reference to the figures. All described and/or illustrated features form the subject matter of the invention on their own or in any combination, regardless of their summary in the claims or their reference back to them. The present invention is illustrated in its first aspect in detail in Figures 386-1 to 386-5 and described below.

In Figure 386-1, a device for vaporizing is shown under A (A1/A2). A1 is a vaporizer and A2 is a VAPE PEN. These have a QR code reader/device in which the white. Furthermore, identification could take place via sensor technology such as a chip RFID or similar.

In B, a cartridge/tank is displayed, which is preferably but not exclusively already full. This tank has a QR code or a chip or similar sensor devices attached so that the reader in A1 and/or A2 can identify it. Since the vaporizer is battery-operated, consumption can be blocked via the QR code or the RFID CHIP or similar by not activating the battery or the vaporizer function. This could be the case for the following scenarios, for example but not exclusively: the insertion of an incorrect product, a ban, a medical order or similar.

Preferably but not exclusively, A is connected to an app using a mobile device (tablet, mobile phone), preferably via WLAN/Bluetooth or similar.

Under D this app gives

1) Information about person, age, gender, etc.

2) Information about ingredients of the cartridge/tank (THC CBD, vitamins, minerals, flavors, etc.)

3) the GPS accesses the app and provides location information

4) Information is stored about the medical findings, any instructions from the attending physician, medical instructions, dosages.

5) a code / a locking option and release is given, this can be entered automatically but also by third parties from outside

In Figure 386-2, A indicates the physician or medical facility that can enter and optimize orders via the cloud or access to the patient’s app. These are stored as an arrangement on the mobile app (B), in a cloud (C) or directly on the vaporizer (C) (vaporizer / PEN).

The possible deposits, preferably but not exclusively, are made under D1 for the order of medicine (e.g. cannabis variety, CBD variety, THC content)

Under D2, the selection is made of the products that the patient is allowed to consume and which function in the devices under C.

Under D3, the number of applications per day and over time is stored.

Under D4, the dose is stored with the number of puffs that can be measured using device C.

Under D5 there are possibilities for the doctor to make adjustments to the dose, medicine etc. based on the patient's development as well as possible communication via physical data delivered via a smart device, e.g. a smart watch.

Under D6, reminders can be installed with an alarm according to the prescribed intake.

Under D7, alarm devices can be installed which, for example, indicate a rapidly rising blood pressure, this is just an example of the possible display via a smart device/smart watch

In Figure 386-3, A defines the user or doctor who can attach or prescribe a smart watch for self-monitoring or for monitoring by the doctor. Using this smart watch, the doctor can monitor and adjust prescriptions and set the medical prescription based on the feedback of the physical, physicochemical and/or chemical data via the smart watch B and/or via a patch C for blood testing, etc. The monitoring under B and C can be recorded at the same time as consumption, which is communicated digitally, via the vaporizer to the smart watch and/or the cell phone/app. This allows the medicine to have a direct effect on the physical, physicochemical and/or chemical data. In Figure 386-4, parents, a third party, a government or medical institution are listed under A. These can use the app to enter information and instructions about the THC content, amounts and time of consumption. Prohibitions are also possible.

These are passed on to the mobile unit/mobile device or cloud (C). Under B, the GPS shows whether you are in a prohibited zone. If the person is in a prohibited zone, consumption is not possible. Free zones are recommended. The prohibitions, information on the content, quantity and time are passed on to the vaporization devices (D) via the mobile device or via the cloud.

In Figure 386-5 there is also the option of attaching the QR code (C) or chip ID to the packaging (A). This is scanned by the mobile device, preferably a cell phone, via the app. This is then passed on to the stored information as previously described in Figures 1 and 2 as well as 3 and 4.

The information stored on consumption via the vaporizer is also related to and set for specific products in relation to the optimal temperatures. This information is also stored via the QR code/sensor chip, which communicates with the vaporizer by inserting or scanning the packaging. It is also possible for the consumer to set temperatures to reduce or increase the effectiveness. The doctor could store this information and, for example, allow three puffs at a temperature of 150 °C and only allow two puffs at a temperature of 180 °C, which increases the active ingredient content (by “puffs” we mean breaths/inhalation).

The present invention will be further described below with reference to a preferred embodiment, in which Figure 394-E provides an introduction to the idea:

The doctor (D) has the option of prescribing and determining medication based on the patient (A) information and the patient findings (A) and of checking and monitoring this as well as the patient's physical/chemical data. To do this, the doctor (D) prescribes a product/medicine (F) based on the findings, which is identified by an identifying feature, for example a QR code. Code and/or a chip. Furthermore, the patient (A) is prescribed or provided with a vaporization device (B2, B3) such as a pen or a vaporizer. These devices (B2, B3) can be identified using a device ID. These devices can be connected digitally to a mobile device (B1), such as a tablet or a cell phone, via Bluetooth, WLAN or similar. The prescribed dosage and intake of the medicine as well as the dosage specifications are passed on to (B) via the cloud (G). The vaporization devices (B2, B3) have a reader (X) to read the QR code and/or RFID chip (F1) attached to the product (F). Verification could also take place via a mobile device (cell phone, tablet/B1). Using the reader installed in the vaporizer (or the mobile device B1) and the identification feature attached to the product/medicine (QR code/chip F1), the device (B3, B2) can recognize the medicine/product (F) used and assign it to the patient using the device ID. The device then follows the instructions/application/order of the doctor (D) via access to the cloud (G). The stored medical order such as dosage, time of application, etc. are implemented by the vaporizer device (B) only functioning in accordance with the application instructions specified by the doctor. The device is also programmed in such a way that it is preferably not functional if other cartridges and/or unknown QR codes/chips are inserted.

Under (C2) you can see various measuring devices that the doctor (D) has assigned to the patient (A). C1 is a smart watch, C3 a smart belt and C21 a smart patch. These devices are intended to be worn by the patient in order to measure physical and chemical data as well as data from the environment. These devices under (C) are in turn connected to the devices (B) via digital connections such as Bluetooth, WLAN or similar. This means that there is a clear connection, particularly in terms of time, between the consumption of the medication by the vaporizer (B) and the physical and chemical patient data (C) measured by the devices C1, 2, C3. The doctor (D) can track this data precisely and evaluate it in statistics. He also has the option of intervening directly in consumption and storing a new medication, consumption order, etc. for the product and the vaporizer via the cloud (G) using the patient's identification features.

Figure 394-1 The doctor (F) enters the patient (A1) and his patient information (A2) into the digital cloud/app/server etc.

The patient (A1) is assigned a vaporizer (B1), which can be assigned via a device ID. This device can optionally be connected to a digital device (tablet, mobile phone, location-based error, etc.) via Bluetooth/WI_AN etc. or similar. On the digital device, the information about the product is assigned using a QR code/RFID (preferably via cloud access). Based on this information stored via QR code/RFID chip, the vaporizer can use its integrated reader (QR code, RFID) to assign the information about which medication it is and, in conjunction with the vaporizer ID, also implement the patient data and the doctor's instructions.

(B2) The cloud knows this device and the patient assigned to this device.

Under C, the doctor selects the various ingredients (C1), which are readable by QR code/RFID attached to the product. The selection is made according to the patient's diagnosis (C2) and/or according to the production information (C3).

Under D, the patient (A1) is provided with a measuring device (D2) which carries out measurements (physical and/or chemical) and transmits them to the cloud (E). These measured data are defined over 24 hours, but also at the time of consumption and the amount consumed. The doctor (F) can then view these in the cloud (G) and adjust, optimize, restrict and block the medication. Production C3 has the option of blocking batches in the event of recalls by entering the information in the cloud (E) and the read QR code/AF ID in the vaporizer no longer works. At the same time, an alarm message can be sent via the connected device (D).

Figure 394-2

The doctor (11) creates the patient (A) with all possible patient data, history as well as origin etc. (A1) After the patient (A) and his diagnosis (A1) have been created, the doctor prescribes his medical order according to the present invention (this could be done by setting time for inhalation, pause between inhalations, time settings for the day and temperature for combustion in the vaporizer. The doctor could also simply set the dose and then issue recommendations for consumption based on the data collected in the cloud.

At the same time, it would be possible to prescribe a smart device such as (smart watch, smart patch, smart belt) to measure the physical and chemical data of the patient and his environment.

Figure 394-3

The patient (C) receives his prescribed medicine according to the present invention based on his patient information (A) and his findings (B). Under D2 D3 D4 he is ordered to be monitored by various devices (smart watch, smart patch, smart body world or similar). Here these devices measure data (E) such as (E1) physical, (E2) chemical data of the patient as well as (E3) data of the environment. According to E1, blood pressure, body temperature, tremors or similar could be measured. Under E2, blood values, oxygen levels, THC/CBD levels or similar could be measured. Under E3, the location and thus the weather conditions, temperature, humidity could be measured via GPS. Furthermore, information such as the order of new medication, change in diet, new clinical picture and E3 could be included for comparison with the data according to E.

Figure 394-4

The cloud (A) communicates with the vaporizers (E) and the digital devices connected to them (mobile phone, tablet or similar). The doctor (C) transmits his prescription/order to the cloud, which can be assigned to the patient via the ID of the devices (E) and the prescribed medication, which can be recognized and defined via the QR code/RFID verification between the product/inserted cartridge and the reader of the vaporizer. Access by the vaporizer or the mobile device (E) connected to the vaporizer enables the prescribed medicine, dosage, etc. to be implemented via the doctor (C) and his patient-related data to the cloud (A). According to the doctor's instructions, the medical prescription could be followed under (F) using information about the product stored in the cloud (A), with the vaporizer (E) implementing the dosage accordingly.

Under (G) timing and dosage as well as temporal intake sequences with built-in breaks could also be implemented.

Under (H) possible blocking could also be done by doctor's order, time information and alarm for consumption by sound or vibration or similar. A blocking would also be possible for timed consumption of various products, or blocking due to recall, which can be defined by QR code/RFID. The device would simply no longer burn this product.

Figure 394-5

Under the Cloud (C), data could be collected worldwide, statistics created and optimized medication could result. The data would be derived from various sources as follows:

Measuring devices (A1,2,3) attached in or to the body (A1, an implanted chip, A3 a smart watch or a body belt, A3 a smart patch for measuring blood count and ingredients.

These would feed the measurement data, chemical as well as physical (B1, 2,3) into the cloud database.

All of this input data would be assigned to the product/medicine as well as the doctor’s prescription via the QR code/chip and to the associated vaporization device, assigned via the device’s ID.

This provides the doctor (D) with real-time monitoring and long-term statistics on consumption, the product and the physical and chemical data of the patient. (D1, D2) Under D3, the doctor has the option of received data/information to adjust the medication in dose, time, etc. Under D4, blocking due to recall of the production QR code and product for Zebisch is possible. Furthermore, blocking at certain times or in certain locations/GPS is possible. It is also possible to influence any addictive behavior of the patient with restrictions or complete blocking.

Under (E) the patient is monitored over time. This means that the physical/chemical data can be assigned to the time of consumption. Furthermore, the number of puffs, the temperature used and the time of application are transmitted to the cloud and assigned to the corresponding measurement using the measuring devices under (A).

By verifying the products via the QR code/chip which is connected to the vaporizer/directly or via mobile device.

This specifies a certain medication and dosage, which can be assigned to the patient via the doctor and the device ID.

Figure 394-6

An optimal setting for dosing could use algorithms based on the plant/product (A), the vaporization temperature (B) and the number or duration of puffs taken by the patient/consumer. All three components (A, B, C) affect the dose that the patient/consumer takes.

An example under D1 and D2:

In D1, a plant is burned at 150 °C and inhaled with three puffs of 2 seconds each, resulting in the dose ABC.

If you burn the same plant at 180 °C and consume it with two puffs of 2 seconds each, the result is the same dose of ABC.

If the same plant is burned at 210 °C and a puff is taken for 2 seconds, the same dose of ABC results. These examples are fictitious, but based on the known information that different plants have different THC contents and active ingredients, that they release different strengths of the active ingredient at different temperatures, and that the number and duration of inhalations determines the dose.

D2

If a plant is burned at 150 °C and inhaled three times for 1 second each, we receive dose ABC.

If we burn the same plant at the same temperature and inhale one puff every 3 seconds, we get the same consumed dose of ABC.

From a medical point of view, it may make sense to take the medication gradually and with time delays, despite the same dose.

Figure 394-6.1

Adjustment of dosage by doctor

The doctor could prescribe medicine (C) and medicine 2 (C1). Using the QR codes/chips in the cartridge (C), device A1, the vaporizer, or device A such as a mobile phone connected to the vaporizer (A1), can assign the product. Using the device ID in devices A and/or A1, the doctor can store the medication and dosage in the cloud, product-specific and assigned to the patient.

An application could look like this:

Application D: D1, one pull for 1 second, pause 1 minute. D2, one pull for 1 second, pause 1 minute. D3, one pull for 1 minute, pause/stop 3 hours

In DE, the application could be implemented in a patient-oriented manner, whereby the patient is informed about consumption and breaks through sound or vibration, or light effects such as a green light or red light. This could also take place via the mobile device, preferably even via voice messages or accompaniment. In case of recall via production, this product-specific via the QR code/chip could function via alarm functions and information via the mobile device.

Application F: F1 one pull 2 seconds, 3 minutes break. F2 one pull for 2 seconds, 3 minutes break. F3 stop for 24 hours, locked

The patient (G) is monitored in parallel with these applications (D) (E) (F) in terms of his physical and chemical data (smart watch, smart belt, smart patch or similar). This information would be passed on to the cloud and accessible to the doctor. The doctor could monitor and adapt his applications D, E, F.

It would also be possible to have a questionnaire, preferably digital, for the patient (G), which could, for example, provide a score for their well-being before, during and after consumption, as well as feedback on the effectiveness of the medicine used and the dose. This would then be added to the other measured and known data for analysis and statistical purposes.

The present invention is additionally described in the further figure S 16.

A

Under A the vaporization device is indicated, which includes a reader in addition to the vaporization function to identify the product under A1 as well as to identify at least one person in order to enable the product information and dosage stored for the product and for the person (A1) as indicated under A2.

B

The information for A is stored under B, one steals, which is fed with various information about the patient B1, about the product/dosage B2, consumption when and what dosage B3, if applicable as specified under B4 weather conditions, which could affect the physical and/or chemical data of the patient, also under B4 possible arrangements or new regulations. Possible exclusion zones could also be set up in which consumption is not permitted

C

These new orders could be stored via the doctor C1, the production/possible recall or similar C3, information on weather conditions via the mobile phone which knows/preferably cell phone C4, the patient himself, who communicates his medical condition and well-being C6, data collected on studies and information about the steal C5, another connected device C2, which takes chemical and physical measurements on the patient, this preferably also connected to device A, the vaporizer, in order to measure the physical and chemical data during the vaporization/consumption of the medication.

C2 could be a device such as a smart watch, a measuring device in the form of a belt, an RFID chip, a functional patch or similar.

Most unwanted side effects of medical cannabis can be avoided as follows:

• start with a low dose – it is better to take several small doses a day;

• wait and check the effect

• take the same (low) dose for several days and observe any side effects that may occur;

• increase the dose slowly, preferably over a long period of time, so that you can determine the optimal dose;

The use of medical marijuana has already been proven by several studies to be effective and free of side effects. For doctors and their patients, the correct dosage is still a big challenge. With conventional medication in the form of tablets, capsules, etc., the dosage is not a problem for doctors. When consuming medical cannabis, the difficulty of controlling the release of active ingredients is particularly evident when vaporizing. However, this is very important in order to treat the patient with as few side effects as possible and to alleviate the symptoms or treat the disease. The dosage varies from patient to patient. Furthermore, contraindications and The solution to this problem was made easier by our innovative application option.

The doctor prescribes a vaporizer for the patient, which is assigned to the patient by the device ID. The device also has a sensor reader, which can use sensors to define the cannabis medicine used using a sensory identification feature (RFID/QR or similar). This device is connected to a cloud. The doctor can thus prescribe all medically necessary parameters and monitor and control the therapy. To prevent misuse, the device can also be assigned to a specific patient.

For example, the number of puffs, breaks between puffs and intakes, or even the vaporization temperature for the medical cannabis can be controlled. To ensure continuous monitoring of the patient and their physical and biochemical values, the patient is provided with at least one measuring device in the form of a body belt, a smart watch, or a needle patch. These are linked to the device ID and thus to the patient. The doctor thus knows in detail how the patient reacts to the respective consumption. He can adjust the parameters accordingly in order to set up an optimal therapy for the patient with as few side effects as possible.

The monitoring also provides excellent protection for high-risk patients such as those with high blood pressure or heart problems. The doctor can intervene immediately or set the device to switch off at a predefined value and the patient cannot use it for the time being. By collecting all data from different patients worldwide via a cloud, indications and dosage can be improved and contraindications and risk factors can be avoided. At the same time, the doctor can benefit from the project by participating in studies.

The device according to the invention is in particular a medical application device which is assigned to a patient via a device ID and which gives the doctor the opportunity to monitor and adjust the patient's dosage via a cloud. Simultaneous monitoring of the patient's physical and chemical data is optionally possible via another measuring device assigned to the patient. In addition to the first aspect described above, reference is made below to the second aspect which builds upon and includes it, in particular through the description of the figures.

Figure 401-1

Two alternative vaporizers are shown under A and B. Both vaporizers have the option of accommodating multiple product cartridges, i.e. devices for vaporizing a vaporizable substance. In Figure A, a revolver device is described under 1. Under B1, a plug-in device with the option of plugging in at a specific time is shown. These are two possible designs. The basic idea is to attach multiple product cartridges (active ingredient) (C, C1, C2), at least two in number, to a vaporizer and to provide the option of vaporizing them, as well as selecting them and thus vaporizing them separately, as well as influencing the type of vaporization. Furthermore, the following describes options for vaporizing different products at the same time, thus enabling a mix of flavors, active ingredients or similar.

The selection for vaporizing the products used could work through a viewing window and manually by pressing a button or some kind of revolver device in the actuation. These would be physical devices and activation of the vaporization.

Figure 401-2

Figure 2 shows, on the one hand, under A and B, the physical activation with the already described rotating mechanism according to a revolver under A1. Under B2, the selection of products in the (magazine-like) plug-in device would be activated with button activation mechanisms. These versions are merely examples. The basic idea is to be able to insert at least two cartridges (E) into a vaporization device and activate them for vaporization as selected.

In C and D the possibility is shown that the vaporizer is connected to a mobile device (tablet, mobile phone or similar). The data stored in the vaporizer inserted product cartridges would be displayed on the mobile device display (C/D).

The identification of the inserted product cartridges (E) would work via QR code or RFID CHIPS attached to the product cartridges, by installing a dedicated reader (A2) in the vaporizer device, which can identify the inserted products. These digitally identified products are then preferably communicated to the mobile devices (tablet, mobile phone) (C/D), preferably via the device ID of the vaporizer device. This gives the user the option of mixing different active ingredients, flavors, vitamins, THC and CBD varieties, selectively switching them on, and adjusting the percentage for each active ingredient.

Figure 401-3

Sketch D shows an evaporator which is provided with a reader (D1, D2, D3) for the identification features (ABC) which are attached to the product cartridges (A, B, C).

The vaporizer D is connected to the mobile devices via Bluetooth, WiFi or similar. An app and/or a cloud now offer the digital option of activating various products/product cartridges on the display (E). A B C is shown on the display, these are the cartridges (A/B/C) inserted into the vaporizer device (D) read by the reader (D1/D2/D3) and digitally communicated to the mobile device (E). In example (E) it is possible to activate or block product cartridges.

In E1 there is a digital option via display to enter percentage settings for each product cartridge used.

In E2 there is a warning / alert under C. This could be a recall from the manufacturer or a defect in the cartridge.

For all settings, a saving button can be pressed to save the selection. The selection of the cartridge, the combustion, the percentage or similar is then saved in a saving list Consumption could also be measured digitally with at least one cartridge. If several cartridges are consumed, the consumption would be added together. Preferably, but not exclusively, the following would be measured: duration of consumption (e.g. 1.2 hours / day 1, 35 minutes day 2), amount of active ingredients consumed (THC, nicotine, shisha vape vapor, vitamins & minerals, etc.).

These could be used for statistical purposes and for optimization. Monitoring for smoking cessation could also measure and monitor the duration of consumption or consumption of the active ingredients, and optimize or adjust the data if necessary (blocking, restricting, specifying amounts and times, etc.). Measurements of the legal maximum consumption could also be taken and compared with the requirements of the respective country/location. Here, a consumption plan could be digitally created and implemented according to the legal or prescribed amount (e.g. prescribed amount 90 grams for 30 days, our device would only allow 3 grams / day of consumption (3 grams x 30 days = 90 grams) or give an alert/message to the user.)

Figure 401-3.1

In E3 you can see a display with different mixing devices, which show different options of the saved settings in Figure 3. These are now on the Saving List and can be selected at the touch of a button without having to make a new setting. (E3)

E4 gives you the opportunity to send recommendations from the Saving List to friends

E5 shows possible tank readings for each cartridge.

E6 offers the option of reordering and paying for tank information that is empty or close to empty online.

Figure 401-4

Under A you can see a vaporizer, under B 3 x cartridges with different THC contents. The vaporizer A is connected to a mobile device (A1) / mobile phone / Tablet or similar connected via Bluetooth, WiFi or similar. The doctor (C) prescribes a THC cartridge based on a medical diagnosis, preferably several, but these are adapted to the diagnosis. The doctor could preferably store the dosage in the cloud and a better result could be achieved by mixing different plant extracts.

Under (D), this possibility could be used to conduct studies to improve the medical applications of various extracts in the correct dosage. The results of the mixture as well as the patient's well-being would be stored in a cloud for optimization and statistical purposes.

Automated settings are also possible under E. These would include, for example, selecting places where smoking is not allowed.

Furthermore, the time setting can be set for each product. For example, medication, cannabis plants that are activated should not be smoked in the evening. They can also be blocked in the event of excessive consumption.

Figure 401-4.1

An extension of the description of Figure 4 is summarized here. A (A) the vaporizer accommodates various product cartridges (B 1, 2, 3, 4) in its receptacles (A 1, 2, 3, 4), preferably ordered by the doctor. As already described, these are read by a reader using their identification feature and then communicated digitally via WLAN and/or Wi-Fi to a mobile device and/or to a cloud (F).

Furthermore, the doctor (E) preferably stores an order for the medication and its intake in the cloud (F). The cloud (F) communicates this to the vaporizer (A) (preferably via mobile device). The device (A) is assigned to a patient by its device identification number. This allows the doctor to store different mixtures and instructions for consumption in the cloud, specific to the patient and the product.

The arrangements (D) are implemented digitally and preferably monitored weekly and also changed if necessary. A possible embodiment, but not exclusively: Weekly monitoring (C) and the possibility of adjustment as an example under C1 and C2. Under C1, one product cartridge is released for consumption each week. This gives an overview of which product cartridge has the best effect on the patient (G). This is monitored by measuring devices that can be assigned to him and the vaporizer device. These are a smart watch, a body belt, a smart patch, but not exclusively. These devices measure chemical and physical data in the patient both at the time of consumption and over the course of the day. Furthermore, the patient communicates with the doctor about his well-being and the effect. This could also be implemented instead of a personal conversation with a digital questionnaire, preferably with a well-being points program.

Under D2, the doctor (E) has the option of changing the application, for example in the form of number of inhalations, time of inhalation, temperature of the vaporizer during inhalation, breaks between inhalations, daily application, type of active ingredient.

The second aspect of the present invention is supplemented by a sub-aspect relating to a multi-vape, i.e. a vaporization device for multiple substances.

Status quo

There are currently many vape devices for vaporizing nicotine-containing and non-nicotine-containing substances that are chemically enriched with flavors for better taste.

Here, the market is divided into single-use and multiple-use vapes. The ingredients to be vaporized are applied to a carrier material. This consists of glycerin, propylene glycol and nicotine (also available as a nicotine-free version). Flavorings are also added.

problem

Especially in single-use, there is only the possibility of consuming pre-made flavours. Furthermore, flavours could be stored at different temperatures Prerequisites for the best consumption taste. Especially in disposable vapes, the consumer does not have the opportunity to actively change the taste.

Solution

The present invention aims to solve this problem and to make an active change that is possible at any time.

For this purpose, two carriers are used, applied separately from each other. The first carrier is preferably for glycerin, propylene glycol and possible nicotine enrichment, the other second carrier is enriched with the flavors

The aroma carrier is interchangeable in the embodiments according to the invention. This could be possible with plug-in devices on the top, bottom or side. The plug-in devices could also be used to create multiple, interlocking, freely selectable variations of aromas.

The strength of the aromas could also be adjusted using manual or digital devices. This could, for example, be regulated by the size of the draft inlet of the aroma carrier.

In the following, direct reference is made to the figure.

Figure 451-6 in A shows another way of providing multiple flavorings via carrier materials. Here, carrier 1 is shown with glycerine, propylene glycol and nicotine. This is heated by a battery-powered mechanism via electrical devices. In D, D1 and D2, the carriers are shown exclusively for the flavors. These preferably but not exclusively (shown here as an example) have their opening on the top through which the aroma can escape and combine with the vapor mixture from E. Preferably, the openings C, C1, C2 can be manually or digitally adjusted in their ventilation flow.

In B you can see a variant according to a revolver device, which as an example holds three aroma carriers in three chambers, these shown here G1, G2, G3, preferably placed in the middle area of the vape device. A cover plate with three openings is placed over this revolver device. The underside of the revolver device can be rotated on its own axis so that all three flavors are freely ventilated, but one cartridge, two cartridges or all three cartridges can also be closed by rotating the revolver device further on its own axis. If the glycerine, propylene glycol and nicotine are now heated in the carrier area E, the vapor mixture is created, which is drawn past the flavor carriers in the revolver device to the mouthpiece when the consumer draws through the mouthpiece F. It absorbs the flavors from the opened flavor carriers.

An embodiment example is described below.

A known product in the form of at least one product cartridge, preferably also several product cartridges, is provided, wherein these product cartridges are filled with a medicament, preferably a herbal, cannabis, powder product, either ground or in a liquid form.

This product is attributed to a device that preferably receives information about the product properties of the product used via a database in order to then adjust the vaporizer/smoking device. In particular, but not exclusively, the temperature and/or the permitted air flow for consumption is regulated here. A temperature is set for vaporization/combustion, with knowledge of the release of the active ingredient of the product used at the temperature used. In addition, the dosage is carried out with knowledge of the active ingredients released, which can be dosed in an adjustable air flow/inhalation of the consumer/patient.

Furthermore, it is possible to adjust the dosage of liquids, for example by injecting a defined amount of liquid from the product cartridge into an evaporation chamber and then burning/evaporating it into the known release of the active ingredients at a defined temperature, which guarantees a targeted dose.

In Figure I, 1 denotes the patient who is communicatively connected to the doctor 10 via a database/cloud. The doctor 10 creates the patient under 8 with his age, gender, medical record, diagnosis and prescription or similar/other.

The database also contains general information about the product information/medication/active ingredient, the product properties, particularly in combustion/evaporation and percentage release of the active ingredient in the form of vapor/smoke/aerosol/mist.

The patient receives a vaporizer/smoking device under 3. This device is provided with an ID that is assigned to the patient and identifiable by the database. The connection to the database 5 can be direct or via a mobile device (mobile phone/tablet), preferably via an app to the database.

Furthermore, at least one product cartridge 2, known via the database of properties, is assigned to the vaporizer / smoking device 3.

The patient also receives a measuring device 4, which monitors the patient's physical and chemical data. These are passed on to the database in real time or at frequent intervals. This enables monitoring 11 as well as early warning signals, measured chemically and/or physically on the patient, which then communicate medication to the patient preferably via vibration, sounds or similar via the mobile devices. In this way, intake, consumption/medication can be recommended early based on the early warning signals measured by the measuring device 4.

The dosage for the product 2, consumed via the device 3 is stored by the doctor 10 in the database 5, this also applies to the prescribed product under 6. The dosage is implemented by knowing the general information 6 and setting in relation to the combination of the product 2 and the combustion / vaporization in the vaporizer / smoking device 3. The data on the product and the vaporization of the product under a certain temperature are stored here. The dosage is thus given according to the release of the active ingredient above a certain temperature, these temperature-regulated releases are already known on the market through vape devices as well as vaporization devices. Another aspect of the dosage is the adjustment of the air draft / air flow. This is preferably set according to air flow systems known on the market, which Regulate airflow by adjusting the top opening of the mouthpiece and/or the bottom of the airflow inlet, this by adjusting the openings through which the airflow passes.

Under 11, the patient is monitored for 24 hours, as well as before, during and after consumption. This allows early warning signals about consumption to be communicated, as well as subsequent adjustments to the medication.

This also makes it possible to optimize patient data worldwide.

Furthermore, two or more product cartridges under 2 can be inserted into the vaporizer 3. This has the advantage that preferred/recommended combinations for consumption in the database are useful for the medication. For example, double indications in the diagnosis can be treated. For example, Tourette and insomnia. These two findings can be combined with a combination in the evening before going to bed, for example.

Furthermore, multiple, different strands in their combination can achieve a better effect, or the same effect but with fewer side effects, since the dosages for each medication / active ingredient are kept lower, but as a whole (combination of three active ingredients, each one third, for example) guarantees the same development / symptom treatment.

Figure II describes the focus of the dosage / dose 4.

The dosage / dose 4 is determined by setting various parameters such as

2. the temperature setting

3. as well as the setting of the consuming air flow / set air flow through the vaporization / smoking device

1. This is done with knowledge of the product being consumed and the product information stored in the database, such as active ingredient, percentage of active ingredient, known release properties of the active ingredient under chemical and/or physical influence. Here, in particular under the influence of a certain temperature and/or a certain air flow. With the knowledge of a fixed constant, the product in the product cartridge 1 and the knowledge of the product properties of this product 1 used, in particular under the adjustable physical and/or chemical influence, here in particular the temperature 2 and the resulting evaporations/smoke formation/aerosols and the percentage of active ingredient 2 released thereby.

With knowledge of the active ingredient proportions 2, the air flow 3 can be adjusted in such a way as to offer a fixed active ingredient proportion for consumption. The setting of the air flow is the length in unit of time, the active ingredient proportion in the air flow and the associated consumption of the known active ingredient proportion, the concentration of the active ingredient (vapor/smoke formation/aerosol and known active ingredient proportion).

The information about the product, product property 1, the information about the active ingredient release and vapor/smoke/aerosol formation for defined temperatures 2, as well as the definition of the air flow/draft created 3 are stored in the database. The vaporizer/smoking device is connected to the database directly or via a mobile phone 6. The reader in the vaporizer/smoking device reads the product cartridge (QR code, RFID or similar) and can use all the stored information (1, 2, 3) to implement the dosage information stored by the doctor in accordance with the invention.

In Figure II 1.1, various product cartridges are shown under 1.1. These are preferably but not exclusively filled with the same amount of active ingredient. Furthermore, a sensory identification feature is attached to cartridges A/B/C. This is preferably but not exclusively in the form of an RFID chip or a QR code. These three cartridges A/B/C are then inserted into a vaporizer. This vaporizer reads the sensory feature and can access the database and process the information stored for this product cartridge and this vaporizer. On the one hand, this is the time of consumption. Here is an example A1/B1/C1/ consumed at intervals of 6 hours each, 9:00 a.m. / 3:00 p.m. / 9:00 p.m. In case study 1.1/1.3, the entire fill level is used up. The fill level is also consumed at a preferred temperature that is recommended for the product. For example, CBD at 180 °C, THC prefers 170 °C. The times of administration are specifically designed by the doctor for the diagnosis and the patient. Furthermore, the database uses data entered into the database when creating the prescription and administration instructions. This data provides information about the diagnosis of the disease and the dosage to alleviate or eliminate the symptoms.

The interval between the times of taking the medication is set and the patient is informed, preferably via a signal, preferably vibration or sound, that he or she needs to take his or her medication again. The intervals here are 6 hours as an example, with 2.5 mg of active ingredient (e.g. THC) each time and can be adjusted depending on the patient, diagnosis and clinical picture.

If the medication is effective for a pain indication and the patient continues to have pain, product cartridges with more active ingredient can be prescribed or the existing product cartridges can be consumed at a shorter interval, for example 4 hours instead of 6 hours. This increases the dose present in the blood.

Example 1

Mr. Müller is a pain patient and receives the product cartridges day 1 to day 7 = three product cartridges to be used. The vaporizer gives a signal to take the drug at 9:00 a.m., 3:00 p.m., 9:00 p.m. The entire amount of the active ingredient in the product cartridge is released. The amount released is 2.5 mg.

After a week, Mr. Müller's pain has lessened, but he still feels slight pain. Mr. Müller's dosage is now being adjusted by the doctor.

Mr. Müller now receives 5 mg three times a day at 9:00 a.m., 3:00 p.m. and 9:00 p.m. These product cartridges, each containing 5 mg, are made available to Mr. Müller ready for consumption.

Mr. Müller always gets very tired after taking 5 mg. The doctor prescribes Mr. Müller 2.5 mg but shortens the intake times by 2 hours. Now Mr. Müller consumes more cartridges at 9:00 a.m., 1:00 p.m., 5:00 p.m. and 9:00 p.m. In 1.2, a vaporization device is shown that can only hold one product cartridge. Here, several product cartridges can preferably be prescribed to the patient and when the signal is given, the patient can insert the product cartridge with the precisely defined amount of active ingredient and smoke. However, as already described, a product cartridge with more active ingredient can also be used. Here, by regulating the temperature, the air flow and the known information about the release of the active ingredient under these known and adjustable parameters (temperature, air flow), the dosage for the patient is delivered as prescribed and stored in the database via the vaporization device and the product cartridge used.

In Figure III.2, under 2.2, a vaporizer with at least two chambers for product cartridges is shown. The vaporizer can read each chamber with a sensor reader using the sensor feature attached to the product cartridge (RFID chip/QR code). Furthermore, the information about the product cartridge and active ingredient and product properties 2.1 are stored in database D. Furthermore, the database communicates the stored data on the products, the product properties and the consumption instructions (vaporization temperature, duration of vaporization, airflow setting, preferably but not exclusively specifically designed for the product properties) to the vaporizer device. To give an example, THC burns best between 170 °C and 210 °C. This temperature defines not only the amount of active ingredient released, but also the ingredients that are released. There are various active ingredients here.

CBD only starts to release its active ingredient at 180 °C. If you want to add a flavor for taste, it depends on the flavor in question, but these usually burn best between 50 °C and 100 °C, but this is not the only temperature.

For this purpose, the information is stored in the database. This information, for the best development, effectiveness of the active ingredient and the taste, as well as the stored dosage instructions, are passed on to the vaporizer. The vaporizer knows which product cartridges are used via the sensory characteristic on the product cartridge through the reader installed in the vaporizer. The vaporizer can thus use this stored information for each product cartridge in the Temperature, in the air flow, in the duration of evaporation / combustion as deposited.

One example is a mixture of THC and CBD, which has been proven in various studies to be effective in pain therapy, symptom treatment for Tourette's syndrome and epilepsy. The problem that arises with a mixture of both active ingredients in one product cartridge is the different temperatures. For example, the CBD can be burned at 190 °C and the THC at 170 °C.

Example 2

Pain patient Mr. Müller cannot sleep in the evening either. In pain therapy, the active ingredients of many THC active ingredients only develop at 210 °C. The product cartridge with THC, which is attributed to Mr. Müller, is instructed in the vaporization council via the database to burn at 210 °C. The combustion time and the air flow are adjusted so that the stored amount of the active ingredient is released. A CBD cartridge is also used, for which a temperature of 180 °C is stored. The dosage setting for the vaporizer is also stored using the data stored in the database about the product, the air flow, the temperature.

Mr. Müller takes 10 mg of THC and 15 mg of CBD before going to bed. The product cartridges vaporize independently and autonomously according to the instructions in the database, but are preferably but not exclusively consumed as a vapor mixture. This could be implemented via an intermediate chamber between the product cartridge and the outlet of the mouthpiece to the consumer/patient.

In Figure IV.3, various product cartridges can be seen under A/B/C. These are provided with a sensory feature, preferably but not exclusively an RFID chip and/or QR code. Each product cartridge is filled with a different product/active ingredient.

These product cartridges are inserted into a vaporizer/smoking device. The product cartridges A1, B1, C1 can be inserted into any receptacle. The vaporizer uses a reader to identify the sensory feature attached to the product cartridge. Thus, the vaporizer has knowledge of the product, the product information and the stored product properties via the database, particularly in the consumption, vaporization and combustion and release of the active ingredient.

The database contains the temperatures that are best suited for vaporization and/or combustion of the respective products/active ingredients/flowers/aromas. These can be aromas that develop their aromas best at a certain temperature. These can be recommended temperatures for CBD and THC in order to best release the active ingredient without burning the product. For THC in particular, there are different temperature settings that release different active ingredients. This is particularly important in the medical field and is crucial for the correct setting and medication for the diagnosis.

Example 3

In the example given, Mr. Müller has a THC cartridge A, which is vaporized at 170 °C in the receiving chamber A1, a CBD cartridge B, which is vaporized at 180 °C in the receiving chamber B1, and the product cartridge C, which is filled with aroma, which has the aroma development without burning at 70 °C.

The information about the vaporization temperatures for the respective products is stored in the database. For the THC range, it is from 170 °C to 210 °C, CBD from 180 °C and flavors mostly under 100 °C. Mr. Müller can also mix products together himself, improving the taste with active ingredients and flavors. By adjusting the air flow and/or the temperature, Mr. Müller can also dose the various product cartridges used via the vaporization device and, if necessary, save them via the database/app.

Patients can therefore assist Mr. Müller, if necessary or in study programs, by increasing or decreasing their settings depending on their well-being and symptom relief and saving the desired result. This can also be done in collaboration with the doctor.

Figure V.4 describes a vaporizer. The active ingredient content under 4.2 is shown as 0%. Under 4.1 a maximum value is set which should not be exceeded. This information is stored in the database, access to the database is via the vaporizer or via a mobile phone / tablet or similar that connects the vaporizer to the database.

Under 4.3, the desired mean value is shown under M. The mean value is a percentage of the active ingredient that alleviates or eliminates the patient's symptoms.

As is known from Tables 1 and 2, which are reproduced below, a rapid effect can be achieved by inhalation/vaporization. This effect then lasts for 2 to 4 hours and then decreases again. In order to guarantee consistent effectiveness, an average value is sought. To do this, the doses are distributed over time in such a way that the dose of the active ingredient decreases, but a desired average value is achieved when the active ingredient concentration in the patient is always present. The following example is given for this purpose.

Example 4

Mr. Müller receives dose 1 at 9:00 a.m. Through inhalation, the effect takes effect after 20 minutes and lasts for around 4 hours. After three and a half hours, the effect wears off. At 1:00 p.m., after 4 hours, dose 2 is consumed. This increases the dose again within 20 minutes and lasts for a further 4 hours. A dose is released at 5:00 p.m. Through frequent intake, defined in time units that take the product information and active ingredient into account in order to guarantee an average concentration of the active ingredient in the patient that treats the symptoms. Mr. Müller therefore does not fall below a certain value, but also does not exceed a maximum value that would be a health risk.

Figure VI.5 shows a combination of vaporizer and oral intake. 5.1 shows the vaporizer in its active ingredient curve (DA), 5.2 shows the oral intake in the active ingredient curve (OR).

Again, a maximum value is shown which should not be exceeded for health reasons. Furthermore, D is the zero value in the concentration. Between the zero value and the maximum value there is a medically desired average value for which a constant concentration must be maintained over a desired period of time.

Example 5 For this purpose, Mr. Müller receives a vaporizer, which is of course connected to the database. This vaporizer product is set up by the doctor via the database. The vaporizer vaporizes the product based on the stored data and releases the active ingredient prescribed by the doctor in the prescribed concentration. When inhaled, the active ingredient takes effect after 20 minutes and lasts for around 4 hours.

Mr. Müller takes this dose 1 DA /5.1 at 9:00 a.m. by inhalation. Müller takes the dose 1 OR /5.2 at the same time, 9:00 a.m., but orally.

The dose inhaled at 9:00 a.m. takes effect after about 20 minutes and lasts for 4 hours. The dose taken orally takes effect after 4 hours and lasts for about 4 to 8 hours. This means that Mr. Müller has a constant dose for at least the next 8 hours until 5:00 p.m. The dosage is now repeated with the same amount and with the same product combination of oral medication and inhalation (dose 2).

THC-A CBD-ATHC CBD CBN CBC combustion

105°C 120°C 157°C 180°C 185°C 220°C230°C

Table 1: Vaporization temperature of various cannabinoids: Cannabinoid Vaporizer T emperature

Parameters Inhalation Oral Ingestion

Onset of action within seconds to a few minutes after 30 - 90 minutes Maximum effect after about 20 minutes after 2 - 4 hours

duration of the effect

2-3 hours approximately 4 - 8 hours

Table 2: Type of application and mode of action: onset and duration of action of medical cannabis when administered inhalatively and orally

The present invention is described in more detail below in the form of particularly preferred embodiments, specifically with regard to a) the revolver mechanism b) the device referred to here as "MediGuard", which communicates via the database in interaction between patient and doctor, whereby the database, the cloud are connected to the smoking device and the measuring device. The database has knowledge of all specified positions as well as the product / active ingredient itself. Everything can be set, adapted, read, stored and monitored via the positions. c) the digital setting via a digital device, preferably a cell phone or tablet, which communicates with the device and digitally receives knowledge of the products. a) the revolver mechanism

The revolver rotation mechanism is rotated clockwise or anti-clockwise into the various usable positions. At least one cartridge but also multiple cartridges are possible, which can be rotated in a uniform direction into at least one smoking position, here also multiple possible in order to mix flavors in a deliberate and defined way. Viewing windows or digital transmission to inform which flavors are being smoked are available. b) the "MediGuard"

The MediGuard is a defined smoking device with a digital reader for inserting a product cartridge that is defined by a digital sensor (RFID/QR). This smoking device is assigned to a consumer/patient. This smoking device is designed to identify the inserted product cartridge. The consumer/patient is created with his/her patient data/physical/chemical properties/illnesses in an app or cloud or similar database.

The product cartridge with its properties and all product information on treatment, chemical and physical properties is stored in the same database/app/cloud.

A chemical and physical data measuring device, assigned to the consumer/patient, is digitally connected to the smoking device and to the cloud/app/database. This measuring device is designed to measure the chemical and physical data of the consumer/patient. The Measurements individually as well as in connection with the smoke device are communicated to the cloud/app/database.

Access to the database for storage and adjustment by a doctor / hospital / caregiver of the consumer / patient / patient themselves in order to create, monitor, check and change data about the patient, course of illness and consumption behavior of the medication.

The database is designed in such a way that the positions of the smoking device, the measuring device, the product cartridge and the consumer/patient are stored. All data of the created positions communicate with the database and the stored instructions for consumption/smoking/medical purposes.

For optimal, precise and exact dosing and adjustment for the consumer/patient, the product cartridge is stored in its chemical and physical properties, its ingredients and active ingredients. The product used is then digitally read by the digital sensor of the smoking device via the cloud, and the smoking device stores all information about the product as well as the intended dosage of consumption.

Consumption is designed and adjustable in that the product is known as follows: in its ingredient in effect, percentage and physical / chemical properties, in its release in the dosage of the active ingredient through temperature-dependent exposure.

This known dose is then compared with the user/patient data and prescribed dosage. This dosage is adjusted to the smoking device and the permitted intake/consumption measured by time, duration of consumption, strength of consumption/intake in relation to the knowledge of the dosage released by exposure to a certain temperature.

The release of the dosage by temperature is stored for each temperature (linear, exponential) in order to allow dosing by physical adjustment at the To deposit and allow smoking device, when is consumption, how much airflow may be consumed, what amount and/or time of airflow/outlet is given.

The interaction of setting the dosage, dispensing through knowledge of the database, the product / product cartridge and thus the active ingredient, amount of the active ingredient, dispensing under temperature influence is given.

The smoking device is set digitally using information stored in the database, adapted to the temperature and the known release of the active ingredient, as well as the digitally set release of the consumption at a specific time and the amount consumed by controlling the airflow and the time of the airflow. This consumption can also be set at a specific time, for example morning / noon / evening.

This allows the doctor to provide a defined medical prescription, this prescription can be guaranteed in terms of active ingredient and intake through the described concept, the behavior of the consumer/patient can be monitored, even at the same time as consumption/during consumption by measuring their chemical and physical data via the measuring device, which simultaneously stores the measured data in the database of the smoking device. This has the advantage of being able to adapt the medical prescription based on the data received. It is also possible to collect the data worldwide via a database in order to optimize the medical application. c) digital adjustment via a digital device

A smoking device, in particular electronic cigarettes such as vapes and the like, are equipped or can be equipped with at least one identifiable product cartridge, which can be digitally identified via sensor technology.

This smoking device, digitally connected to another digital device (mobile phone, tablet or similar), is designed so that the information about the product cartridges used is communicated to this digital device. This can preferably be read out and displayed in an associated app. The display defines the product cartridges. It is possible to select or deselect the product cartridges on the display. The display opens the Possibility to mix each product cartridge with each other. The display offers the possibility to set each individual product cartridge in percentage (via a slider, preferably from left to right) to set the strength (via digitally attached minus and plus signs or similar). These specified and selected settings are then passed on from the mobile device to the smoking device and implemented as instructed

The implementation of the digital setting and the adjustment of the strength of consumption can work through different heating elements, and/or by increasing or decreasing the temperature of the individual pressure cartridges, and/or by regulating the aerosol/smoke emitted by your product cartridge, and/or by mixing the flavors in a collecting tank designed for this purpose, in which the added flavors, selected in their quantity, are mixed and vaporized.

Another embodiment is given below.

setting the dosage option

Option 1

A product cartridge is inserted into the vaporizer / smoking device, the filling quantity of which (liquid / solid) is known. Furthermore, the proportion of active ingredient is known, preferably but not exclusively THC / CBD,

Now a temperature is set within a recommended temperature range, preferably but not exclusively between 180 °C and 210 °C. For example: Marijuana flower, 2 g ground, with a known THC content of 5% (5 mg) is filled into the product cartridge.

This product cartridge is inserted into the vaporizer/smoking device and vaporized/burned at a set temperature of 175 °C. The time unit of combustion/evaporation until the product used in the product cartridge is completely consumed is measured. The product cartridge contains 2 g, which corresponds to 2 * 5 mg of active ingredient. Total active ingredient in quantity 10 mg. The complete consumption of the used filling quantity (marijuana flower) when vaporizing/smoking is 100 seconds. This means that an active ingredient content of 0.1 mg per second can be defined.

This makes it possible to dose with a fixed and released air flow. For example, 3 x air puffs lasting 3 seconds each could release an active ingredient content of 3 x 0.3 mg, which corresponds to an active ingredient absorption of 0.9 mg.

Which air flow and which air volume is chosen can be decided later by blood tests and the test results of the THC content. A higher or lower air flow in terms of air volume (volume / ml) can possibly change the bioavailability. This can be determined in studies as described.

Option 2

The inserted product cartridge with a known product (preferably but not exclusively cannabis / THC / CBD) is consumed (vaporized / burned / consumed / vaporized) at a fixed temperature and an almost set air flow. This air flow is measured using a sensor device according to the respective active ingredient: proportion and resulting amount of the active ingredient. This proportion is measured simultaneously in a unit of time. Example: per second of air flow, fixed and known, with an almost set temperature and known. The resulting absorbable active ingredient content in the defined air flow can later be used to adjust the patient's dose.

Possible evaporation/combustion/but not limited to:

Heating elements on or in the product cartridge Heatable container in which the product cartridge is inserted Hot air flow that passes through the product cartridge past the ground cannabis flower General use of cannabis

In principle, cannabis can be inhaled or taken orally. Medical cannabis as a whole flower should always be preferred by inhaling it by smoking or vaporizing it with a vaporizer, as this does not produce any potentially harmful substances. THC, the main active ingredient in cannabis, is found in a pharmacologically inactive form. In order to convert the THC-A into an active, effective form, the flowers must be heated.

We recommend using a vaporizer in which a precisely defined amount of flowers is heated to a controlled temperature of 180 °C to 210 °C. This creates an aerosol containing the active ingredient, which is inhaled.

Compared to inhaled cannabis flowers, the effect of orally taken cannabis extracts generally takes a little longer to take effect. The slow increase in the concentration of the active ingredient in the blood and the longer duration of action promote the development of a constant level of the active ingredient in the body. Established indications for medical cannabis

Established indications for medical cannabis include chronic - especially neuropathic - pain, spasticity in MS, loss of appetite, nausea and vomiting.

Evidence of positive effects ranges from neurological (spasticity and pain of various causes, hyperkinetic movement disorders) to internal (arthritis, ulcerative colitis, Crohn's disease) and psychiatric illnesses (depression, anxiety disorders, post-traumatic stress disorder, ADHD, sleep disorders), epilepsy, Tourette's, etc.

Measuring device from example

Example 1 :

Monitoring of the patient's physical and chemical values over 24 hours or more, in connection with the set dosage via the implementation of the product cartridge with a defined vaporization / smoking device described in the invention.

Preferably, but not exclusively, the vaporizer/smoking device is also connected digitally (for example via Wi-Fi/Bluetooth or similar). This has the advantage that the patient is explicitly monitored when consuming the active ingredient. For example, blood pressure goes up, body temperature rises, monitoring of blood sugar levels/insulin, especially for diabetics. Based on this data, the doctor has the option of re-adjusting and adjusting the patient. Example 2

This also provides the opportunity to carry out various study programs, as well as blind studies/placebo. Here, the dosage of the product itself in terms of its active ingredient and active ingredient content, the recommended dosage, duration of use, number of daily doses, and the time interval between doses are recorded.

These are examples, but not limited to the invention. And furthermore, the above-mentioned options for adjustment are compared with the well-being, the symptoms to be treated, and the physical condition of the patient.

dosage of cannabis

Cannabis should always be dosed gradually at first. Depending on the THC content of the individual variety, the initial dose of flowers should be 0.25 g to a maximum of 1 g. Depending on effectiveness and tolerability, the dose can be increased by around 25 mg to 100 mg of cannabis (corresponding to 2.5 mg to 5 mg THC depending on the variety) every 1 to 3 days. The maximum daily dose is 3 g and should not be exceeded. Close consultation with the doctor is always required for individual dosage.

The intake of cannabis extracts and the exact dosage depend on the active ingredient content of the extract, the amount and concentration of the active ingredient released by the vaporizer/smoking device and the patient's symptoms, as well as general information about the patient, for example, but not limited to, gender, age, weight, medical history. In order to be able to determine the individual dose for optimal therapeutic success, treatment should begin with a lower dosage and slowly increase over a period of several weeks.

Dosage Example Tourette

According to the author, treatment of Tourette syndrome with medical cannabis can be started with a low THC dose of 2.5 mg to 5 mg per day and gradually increased to a dose of 10 mg to 20 mg per day depending on effectiveness and tolerability. The dose should be divided into two to three doses per day. There are also initial indications that the administration of a Combination preparations of tetrahydrocannabinol (THC) and cannabidiol (CBD), such as Sativex®, are beneficial and have a better effect.

For this gradual increase in doses, our invention makes it possible to store the increase in dose in a defined time window, adapted to the patient's information (age, gender, weight, etc.) in the database. This means that the prescribed intake can then be implemented in accordance with the specifications stored by the doctor in the database via the vaporizer/smoking device and the prescribed product cartridge, whose ingredients and properties are known, in dose, recommended intake and dose increase, without causing sources of error when the patient takes the medication. These are precisely defined by the fixed parameters in dose, intake time, duration and increase in dose according to the specifications in the database.

Case example Tourette: Attitude of patient Mr. Müller

1. Mr. Müller receives his vaporizer with product cartridge

2. Vaporizer, the prescribed product cartridge and the patient's intake instructions are stored in the doctor's database

3. Intake plan as follows

Day 1 2.5 mg

Day 2 5mg Day 3 5mg Day 4 5mg Day 5 2 x 5mg (morning/evening) from day 15 2 x 10 mg (morning and evening) Day 15: Feedback from monitoring device on patient: Blood pressure too high

Day 16 Doctor changes the prescriptions in the database to 4 x 5 mg

Day 17 Patient consumes 4 x 5 mg every 4 hours, good tolerance / no increase in blood pressure, relief of Tourette symptoms, patient feedback positive, well-being from day 18: from a medical point of view, dosage ideal, relief of symptoms, no medically concerning abnormalities, well-being of the patient. Result: Patient is considered to be adjusted

Database is read via Kl and patient data, findings and dosage settings are used to optimize Active ingredient mixture at least two cartridges

Mixed combinations of active ingredients can also be offered on at least two product cartridges and, depending on the location, study location and monitoring of the database, can be adapted individually to the patient, as well as the location and findings.

Especially in cases of ADHD, epilepsy and Tourette, doses of a CBD and THC mixture have been proven to alleviate symptoms.

The number of studies is currently small and weak. Our innovation can simplify various studies and initiate them worldwide by using artificial intelligence to evaluate the information fed into the database by various hospitals and doctors around the world. The data on dosage and indication can be continuously improved on a patient-specific and/or symptom- and diagnosis-specific basis and patients can be offered the best medication and dosage.

A product cartridge with a known active ingredient release in combination with the vaporizing/smoking device is used with CBD. A second product cartridge with a known active ingredient release in combination with the vaporizing/smoking device is used with THC.

Here, the doctor can manually adjust different dosages or artificial intelligence can divide different studies into study groups and determine the dosages for each cartridge. The data collected from this on well-being, relief of symptoms, etc. are fed into the database directly via the patient and/or via the hospital/doctors.

The advantage of this device is that the active ingredient mixtures can be adjusted again and again by simply adjusting the consumption approvals and dosage via the database

early warning system

Another possibility for improvement, reduction, symptom control and medical indication is the 24-hour monitoring of the patient with the said measuring device. This measuring device is digitally connected to the vaporizer and simultaneously via this or via mobile phone or directly to the database.

Timely medication

The measurement involves monitoring physical and/or chemical patient values to enable timely medication.

This provides the opportunity to store information related to the findings that allows for an early warning of one and/or several symptoms. This early warning has the advantage of allowing the active ingredient to alleviate the symptoms to be consumed in advance, preferably by inhalation due to its faster effectiveness.

There are various early warning bracelets available, especially for Tourette's, which monitor patients and can identify a seizure up to 30 minutes in advance (five out of six patients).

Here, for example, the patient Mr. Müller can receive his already set dose (see above) in advance. This can be done via a warning signal function, e.g. vibration of the bracelet. The release in early warnings is stored in the database and allows consumption outside of the specified dosage and intake instructions.

Adjusting the dose to a constant mean value

Here, a medium, medical dosage can be set to achieve a symptom-relieving / alleviating mean value in the patient's blood

This is done by adding a dose at a defined time interval throughout the day to achieve an average (from - to). This average to be achieved is known to eliminate and/or alleviate the patient's symptoms.

Furthermore, product combinations of inhalation and oral administration can be offered as a combination product. And the advantage of inhalation is the maximum release of the active ingredient after 20 minutes, duration of effect 2 to 3 hours. With oral administration, the maximum release of the active ingredient is 2 to 4 hours and lasts 4 to 8 hours. In this way, an overlapping average can be achieved from the combination, since the effect of inhalation ends when the effect of the oral administration reaches its maximum.

The correct temperature setting of the vaporizer is another important point in vaporization. A low temperature setting has a completely different effect than a high temperature. This is because the active ingredients contained evaporate at different temperatures. THC, the main active ingredient of the cannabis plant with a euphoric, pain-relieving and relaxing effect, evaporates from around 160 °C. The second most common active ingredient, CBD, which has an anti-anxiety and muscle-relaxing effects, has its boiling point at 160 °C to 180 °C.

The sedative and antibiotic CBN evaporates at 186 °C, while the pain-relieving THC-V only evaporates at 220 °C, which is almost no longer evaporation, but rather partial oxidation.

Claims

patent claims 1. Smart device for consumer-specific adaptation of substance consumption, comprising • a device for receiving, identifying and processing a substance to be consumed, • at least one substance to be consumed which is clearly identifiable by a sensory feature such as a QR code or a sensor chip, • at least one mobile unit worn by the consumer and/or close to the body, • at least one wireless network communication between all user-carried units, • at least one wireless network connection to a central or decentralized data server for the exchange of data collected by the consumer, • at least one interface for medical professionals to assess the data collected by consumers. 2. Smart device for digitally adjusting the state of a substance to be consumed, wherein the device for receiving an inserted substance to be consumed is designed to bring the substance into a consumable state, in particular an aggregate state, and is identifiable by the device through a sensory feature, such as a QR code or a sensor chip 3. Smart device according to claim 1 or 2, wherein the device and/or the mobile unit is/are connected to a body-worn device, such as a smart watch or the like, via a wireless data interface, wherein the body-worn device is designed to record physical and/or physical and/or chemical and/or pharmacological data of a person wearing the body-worn device, to compare it with the stored data and/or instructions and to interact based on the comparison, wherein an exchange of the data takes place with a central or decentralized data server. 4. Smart device according to one of claims 1 to 3, wherein the device is connected to a mobile unit, such as a smartphone, which is designed to retrieve data and/or instructions stored for the at least one substance to be consumed via an app or direct access to a central or decentralized data server and to execute these via a digital connection to the device, as well as to send data obtained via the mobile unit worn close to the body to the central or decentralized data server. 5. Smart device according to one of claims 1 to 4, wherein the substance to be consumed can be released by medical professionals in predeterminable amounts, units or time periods and wherein the active ingredient concentration and the amount of active ingredient released can be regulated by adjusting the temperature or by using a nebulizer unit and the absorption can be monitored by monitoring the inhalation behavior (duration, depth). 6. Smart device according to one of claims 1 to 5, wherein the data obtained by the body-hugging unit and sent to the central or decentralized data server via the mobile unit, such as the smartphone, can be processed there and compared with consumer-specific data typical of the disease or scientific study databases in such a way that the consumer receives a recommendation via the mobile unit, such as the smartphone, with information on the dosage and type of at least one substance for preventing or alleviating acute attacks of the disease, in a temporally close connection with the data collected. 7. Smart device according to one of claims 1 to 5, wherein the data obtained by the body-hugging unit and sent via the mobile unit, such as the smartphone, to the central or decentralized data server can be processed there and compared with consumer-specific data typical of the disease or scientific study databases in such a way that the consumer receives a recommendation via the mobile unit, such as the smartphone, with information on the dosage and type of at least one substance for preventing or alleviating permanent disease patterns, in a temporally close connection with the data collected. 8. Smart device according to claim 6 or claim 7, wherein the consumer receives the recommendation with information on the dosage and type of the at least one substance at definable time intervals. 9. Aerosol-forming device comprising • a device for converting a substance into an aerosol or a state of aggregation, • a receiving device for substance containers, wherein the receiving device is designed to receive at least two substance containers simultaneously, which can be alternately connected to the device for evaporation. 10. Aerosol-forming device according to claim 9, wherein the device for converting a substance into an aerosol or a state of aggregation is the device for receiving an inserted substance to be consumed according to one of claims 1 to 5. 11. Aerosol-forming device according to claim 9, wherein the receiving device for substance containers is designed like a revolver drum and the fill level can be displayed either directly on the substance container or via a display on the aerosol-forming device or via an app. 12. Aerosol-forming device according to claim 9, wherein the receiving device is designed like a magazine and the fill level can be displayed either directly on the substance container or via a display on the aerosol-forming device or via an app. 13. Aerosol forming device according to claim 9, wherein the aroma to be vaporized can be selected from the at least two substances located in the magazine, wherein the revolver drum-like mechanism is used. 14. Aerosol-forming device according to claim 9, wherein the substances can be mixed with one another in a freely selectable ratio controlled mechanically or digitally by the consumer via the app before they are vaporized from a collecting container provided for this purpose, as well as by several steam generators within the aerosol-forming device from at least two substances can be processed in a temperature-specific manner and a consumer-specific vapor mixture can be adjusted. 15. Aerosol-forming device according to claim 9, wherein the combination of at least two substances mixed together can be stored at least on the smartphone or on the central or decentralized data server and can thus be accessed by other consumers at any time.